• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

A comparative study of middle ear surgeries under sedation and local anaesthesia with midazolam plus dexmedetomidine versus midazolam plus nalbuphine

    Sangita Agale Eram, Surekha More, Shailendra Chauhan, Vivek Patange

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 6746-6751

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Monitored Anaesthesia Care (MAC) typically involves administration of local anaesthesia in combination with IV sedatives, anxiolytic and/or analgesic drugs.  Present study was aimed to compare middle ear surgeries under sedation and local anaesthesia with midazolam plus dexmed versus midazolam plus nalbuphine.
Material and Methods: Present study was a prospective, comparative study conducted in patients 18-60 years age, either gender, ASA Grade I /II, posted for middle ear surgery under Sedation & local anaesthesia. In first group MD, patients received intravenous inj. midazolam 1 mg plus inj. dexmedetomidine 1 ugm /kg bolus and 0.5 ugm kg added in 100 ml NS infusion, given at 0.3 to 0.4 ugm/ min. In second group MN, patients received intravenous inj. midazolam 1 mg plus inj nacphin 10 mg slowly.
Results: Patients were randomly divided in two groups of 30 each. In present study, age, gender, BMI, ASA grade, type of surgeries (Tympanoplasty, mastoidectomy, stapedectomy) & duration of surgery was comparable & difference was not statistically significant. Ramsay Sedation Score (RSS) at 30,40 & 90 minutes was better in MD group as compared to MN group, difference was statistically significant. Visual Analogue Score (VAS) at 20, 30,40, 60 & 90 minutes was better in MD group as compared to MN group, difference was statistically significant. Patient & Surgeon satisfaction score was better in group MD as compared to group MN, but difference was not statistically significant. Conclusion: Dexmedetomidine with midazolam was better than nalbuphine with midazolam, with respect to sedation, analgesic effect, patient & surgeon satisfaction.
Keywords:
    Dexmedetomidine midazolam Nalbuphine middle ear surgery
  • PDF (293 K)
  • XML
(2022). A comparative study of middle ear surgeries under sedation and local anaesthesia with midazolam plus dexmedetomidine versus midazolam plus nalbuphine. European Journal of Molecular & Clinical Medicine, 9(7), 6746-6751.
Sangita Agale Eram, Surekha More, Shailendra Chauhan, Vivek Patange. "A comparative study of middle ear surgeries under sedation and local anaesthesia with midazolam plus dexmedetomidine versus midazolam plus nalbuphine". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 6746-6751.
(2022). 'A comparative study of middle ear surgeries under sedation and local anaesthesia with midazolam plus dexmedetomidine versus midazolam plus nalbuphine', European Journal of Molecular & Clinical Medicine, 9(7), pp. 6746-6751.
A comparative study of middle ear surgeries under sedation and local anaesthesia with midazolam plus dexmedetomidine versus midazolam plus nalbuphine. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 6746-6751.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 5
  • PDF Download: 19
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus